Because the serum and pulmonary levels achieved with penicillin or related
drugs are several times higher than the MICs of the strains, most pneumonia
s caused by S. pneumoniae currently defined as not susceptible to penicilli
n should respond well to treatment with a beta-lactam antibiotic using opti
mal dosing. All studies currently available comparing mortality between pat
ients with pneumonia caused by nonsusceptible and susceptible pneumococci a
gree that resistance of up to MIC 2 mg/L is not independently associated wi
th an increased mortality. Most, but not all, studies also could not prove
an effect of microbial resistance on morbidity. Treatment failures, however
, may occur at higher levels of resistance and, therefore, a change in the
definition of susceptibility categories toward higher cut-offs for S. pneum
oniae seems to be reasonable.